PA

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Retz M et al. - This review summarizes the results of first-line and second-line systemic chemotherapy for advanced urothelial carcinoma as well as data from adjuvant and neoadjuvant trials for locally advanced bladder cancer. Whereas conventional systemic chemotherapy prevailed for over two decades, targeted therapeutics have been introduced to treat urothelial cancer during recent years.

Today in Clinical Pharmacology...keeping you current

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09

Statins and noncardiac surgery: Current evidence and practical considerations
Cleveland Clinic Journal of Medicine, 12/04/09

Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09

Today in Hematology/Oncology...keeping you current

Intraspinal techniques for pain management in cancer patients: a systematic review
Supportive Care in Cancer, 12/04/09

Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
JACC - Journal of the American College of Cardiology, 12/04/09

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09